Anakinra en es it fr

Anakinra Brand names, Anakinra Analogs

Anakinra Brand Names Mixture

  • No information avaliable

Anakinra Chemical_Formula


Anakinra RX_link

Anakinra fda sheet

Anakinra msds (material safety sheet)

Anakinra Synthesis Reference

No information avaliable

Anakinra Molecular Weight


Anakinra Melting Point

No information avaliable

Anakinra H2O Solubility

No information avaliable

Anakinra State


Anakinra LogP


Anakinra Dosage Forms


Anakinra Indication

For treatment of adult rheumatoid arthritis

Anakinra Pharmacology

Used to treat rheumatoid arthritis, Kineret blocks the biologic activity of IL-1 by competitively inhibiting IL-1 binding to the interleukin-1 type I receptor (IL-1RI), which is expressed in a wide variety of tissues and organs.1 IL-1 production is induced in response to inflammatory stimuli and mediates various physiologic responses including inflammatory and immunological responses. Patients with rheumatoid arthritis have elevated levels of IL-1. The levels of the naturally occurring IL-1Ra in synovium and synovial fluid from rheumatoid arthritis (RA) patients are not sufficient to compete with the elevated amount of locally produced IL-1. Increasing the levels of IL-1Ra by artificial means reduces the negative effects (cartilage degradation, bone resorption) of IL-1.

Anakinra Absorption

No information avaliable

Anakinra side effects and Toxicity

No information avaliable

Anakinra Patient Information


Anakinra Organisms Affected

Humans and other mammals